ACOG (Alpha Cognition) 3-Year Share Buyback Ratio: -99.90% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ACOG Alpha Cognition Inc ACOG
34 GF Score
Price $8.23
! 3 Warning Signs
View Full Analysis

What is Alpha Cognition 3-Year Share Buyback Ratio?

Alpha Cognition ACOG +6.33% 34 3-Year Share Buyback Ratio is -99.90 as of Mar. 2026. GuruFocus rates ACOG with a GF Score™ of 34/100. The stock has 3 warning signs investors should review. Among 1,196 Biotechnology companies, Alpha Cognition ranks worse than 91.05% on this metric.

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. A positive ratio may indicate share buybacks over the period, while a zero or negative ratio may reflect no repurchases or potential share issuance. Alpha Cognition's current 3-Year Share Buyback Ratio was -99.90%.

The historical rank and industry rank for Alpha Cognition's 3-Year Share Buyback Ratio or its related term are showing as below:

ACOG' s 3-Year Share Buyback Ratio Range Over the Past 10 Years
Min: -99.9   Med: -80.9   Max: -31.6
Current: -99.9

During the past 6 years, Alpha Cognition's highest 3-Year Share Buyback Ratio was -31.60%. The lowest was -99.90%. And the median was -80.90%.

ACOG's 3-Year Share Buyback Ratio is ranked worse than
91.05% of 1196 companies
in the Biotechnology industry
Industry Median: -11.75 vs ACOG: -99.90

Alpha Cognition (NAS:ACOG) 3-Year Share Buyback Ratio Explanation

A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.


Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.


Alpha Cognition 3-Year Share Buyback Ratio Related Terms


ACOG vs HURA, MENS, ENLV: 3-Year Share Buyback Ratio Comparison

For the Biotechnology subindustry, Alpha Cognition's 3-Year Share Buyback Ratio, along with its competitors' market caps and 3-Year Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alpha Cognition 3-Year Share Buyback Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alpha Cognition's 3-Year Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where Alpha Cognition's 3-Year Share Buyback Ratio falls into.


ACOG
34GF Score
Alpha Cognition Inc ACOG
3-Year Share Buyback Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alpha Cognition 3-Year Share Buyback Ratio Calculation

This is the annualized percentage change in shares outstanding from three years ago to the current year. The annualized percentage change is calculated with expontential compound based on the latest four years of annual data on Shares Outstanding (EOP).

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

What does a 3-Year Share Buyback Ratio of -99.90 mean?
Alpha Cognition (ACOG) has a 3-Year Share Buyback Ratio of -99.90 as of Mar. 2026. The 3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. View historical data for Alpha Cognition and its competitors. According to the industry distribution chart, Alpha Cognition ranks #1089 out of 1196 companies in the Biotechnology industry, placing it in the top 91.1%.
Is Alpha Cognition's 3-Year Share Buyback Ratio too high?
Alpha Cognition's current 3-Year Share Buyback Ratio is -99.90. Based on the distribution chart, Alpha Cognition ranks #1089 out of 1196 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Alpha Cognition has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Alpha Cognition's 3-Year Share Buyback Ratio compare to HURA and MENS?
According to the Biotechnology industry distribution chart, Alpha Cognition ranks #1089 out of 1196 companies for 3-Year Share Buyback Ratio. This places Alpha Cognition in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Share Buyback Ratio for a Biotechnology company?
A good 3-Year Share Buyback Ratio depends on the Biotechnology industry context. However, 3-Year Share Buyback Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Share Buyback Ratio mean?
A high 3-Year Share Buyback Ratio can signal that a stock is expensive relative to its fundamentals. The 3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. View historical data for Alpha Cognition and its competitors. Alpha Cognition's current 3-Year Share Buyback Ratio is -99.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alpha Cognition stock overvalued right now?
Alpha Cognition (ACOG) has a current 3-Year Share Buyback Ratio of -99.90. The current 3-Year Share Buyback Ratio is -99.90. Alpha Cognition's overall GF Score™ is 34/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Share Buyback Ratio calculated?
3-Year Share Buyback Ratio is calculated from a company's financial statements. For Alpha Cognition (ACOG), the current 3-Year Share Buyback Ratio is -99.90 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Alpha Cognition Business Description

Other Exchanges 7N70:Germany
Address 1200 - 750 West Pender Street, Vancouver, BC, CAN, V6C 2T8
Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimers disease, for which there are limited or no treatment options. The Companies current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Companies commercial development program for ZUNVEYL is focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.
34GF Score

Get the complete analysis for ACOG

3-Year Share Buyback Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$8.23
Price